SynthesisInternational journal of impotence research2026
Hard-flaccid syndrome: a systematic review of aetiopathophysiology, clinical presentation and management.
Synthesis in International journal of impotence research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hard-flaccid syndrome (HFS) is a rare condition characterised by a semi-rigid penis in the flaccid state, often accompanied by perineal and urinary symptoms. It may also induce psychological distress, which can exacerbate physical symptoms, creating a vicious cycle. There is currently no standardised treatment for HFS, and management typically focuses on addressing both the underlying causes and presenting symptoms. A systematic review of the literature identified 8 eligible studies. Although the exact aetiopathogenesis remains unclear, it is hypothesised that an initial penile trauma may trigger a cascade of neurovascular and inflammatory events. The associated psychological impact may further perpetuate symptoms, reinforcing the cycle of dysfunction. Common symptoms include perineal pain, urinary disturbances, and erectile and ejaculatory dysfunction. Evaluation involves a comprehensive clinical history, relevant blood and radiological investigations to exclude other pathologies, and the use of symptom questionnaires. Reported treatments include phosphodiesterase-5 inhibitors, anxiolytics, low-intensity shockwave therapy, pelvic floor physical therapy, spinal surgery, and biopsychosocial therapy. Management should be individualised, with a focus on relieving symptoms and breaking the self-perpetuating cycle of HFS. Further evidence-based studies are needed to better understand the pathophysiology of HFS, as well as to develop clear diagnostic criteria and management guidelines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.